Impact of specialist neurovascular care in subarachnoid haemorrhage
- PMID: 25839916
- DOI: 10.1016/j.clineuro.2015.03.006
Impact of specialist neurovascular care in subarachnoid haemorrhage
Abstract
Background: The management of neurosurgical disorders has become increasingly specialised. The care of patients with subarachnoid haemorrhage (SAH) has generally been part of core neurosurgical practice, provided by general neurosurgeons whatever their specialist interest. The aim of this present study therefore is to ascertain if, and to what extent care provided by a dedicated neurovascular team (compared to care provided by a general neurosurgical team) change patient disposition in SAH.
Methods: This is a retrospective analysis of SAH patients, identified from a departmental database of a single neurosurgical centre. In 2008, the service was reorganised such that a neurovascular team cared for all SAH patients. We compared clinical outcome in people admitted prior to this service reorganisation (Period A, 2004-2007) with patients admitted afterwards (Period B, 2009-2011). Survival and recovery were assessed according to the Glasgow Outcome Scale (GOS). Multi-factorial logistic regression analysis was performed to determine the injury and age adjusted incidence of complications, odds of survival at discharge, discharge home, mortality, good recovery (GOS 5) and favourable outcome, by dichotomising GOS (GOS 4-5 vs. GOS 1-3) at 3 months.
Results: 1114 patients were included in the study. The mean age of patients presenting in Period A (n = 543) was younger [50 years (SD 13.5)] than those in Period B (n = 571) [53 years (SD 13)]. Patients admitted in Period B were more likely to present as poor grade (World Federation of Neurological surgeons (WFNS) grades 4 and 5) compared to Period A (26.5% vs. 21.3%). No statistical differences between the groups in the incidence of pre-operative re-bleeding (3% vs. 5%) or rates of delayed cerebral ischaemia (16.1% vs. 16.1%) were observed. After adjustment for age, sex and injury severity, the odds of patient time to discharge, discharge home and good recovery (GOS 5) were 27% (p < 0.001), 45% (p = 0.001) and 93% (p < 0.001) higher respectively in Period B than Period A.
Conclusions: The data presented here demonstrates that management of SAH by a dedicated neurovascular team improves the potential for patient recovery.
Keywords: Functional recovery; Neurointensive care; Organisation of stroke care; Outcome measures; Subarachnoid haemorrhage.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository.J Neurosurg. 2015 Mar;122(3):644-52. doi: 10.3171/2014.10.JNS132694. Epub 2015 Jan 2. J Neurosurg. 2015. PMID: 25554825
-
Modified World Federation of Neurosurgical Societies subarachnoid hemorrhage grading system.World Neurosurg. 2015 May;83(5):801-7. doi: 10.1016/j.wneu.2014.12.032. Epub 2014 Dec 20. World Neurosurg. 2015. PMID: 25535068
-
Impact of early-onset seizures on grading and outcome in patients with subarachnoid hemorrhage.J Neurosurg. 2015 Feb;122(2):408-13. doi: 10.3171/2014.10.JNS14163. Epub 2014 Dec 5. J Neurosurg. 2015. PMID: 25479126
-
Causes of neurological deficits following clipping of 200 consecutive ruptured aneurysms in patients with good-grade aneurysmal subarachnoid haemorrhage.Acta Neurochir (Wien). 2011 Feb;153(2):295-303. doi: 10.1007/s00701-010-0896-y. Epub 2010 Dec 14. Acta Neurochir (Wien). 2011. PMID: 21153905 Review.
-
The epidemiology, diagnosis and treatment of subarachnoid haemorrhage in Nigeria: what do we know and what do we need to know?Br J Neurosurg. 2004 Aug;18(4):362-6. doi: 10.1080/02688690400005057. Br J Neurosurg. 2004. PMID: 15702835 Review.
Cited by
-
Clinical characteristics and factors relating to poor outcome in patients with aneurysmal subarachnoid hemorrhage in Vietnam: A multicenter prospective cohort study.PLoS One. 2021 Aug 13;16(8):e0256150. doi: 10.1371/journal.pone.0256150. eCollection 2021. PLoS One. 2021. PMID: 34388213 Free PMC article.
-
Predictive validity of the prognosis on admission aneurysmal subarachnoid haemorrhage scale for the outcome of patients with aneurysmal subarachnoid haemorrhage.Sci Rep. 2023 Apr 25;13(1):6721. doi: 10.1038/s41598-023-33798-5. Sci Rep. 2023. PMID: 37185953 Free PMC article.
-
Validation of the accuracy of the modified World Federation of Neurosurgical Societies subarachnoid hemorrhage grading scale for predicting the outcomes of patients with aneurysmal subarachnoid hemorrhage.PLoS One. 2023 Aug 22;18(8):e0289267. doi: 10.1371/journal.pone.0289267. eCollection 2023. PLoS One. 2023. PMID: 37607172 Free PMC article.
-
Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.BMC Neurol. 2020 Nov 3;20(1):401. doi: 10.1186/s12883-020-01908-9. BMC Neurol. 2020. PMID: 33143640 Free PMC article. Clinical Trial.
-
Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation.Stroke. 2023 Jul;54(7):1930-1942. doi: 10.1161/STROKEAHA.123.040205. Epub 2023 May 26. Stroke. 2023. PMID: 37232189 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources